Program for preventing diabetes in rural communities
Rural Alliance for Diabetes Prevention
This study is testing whether group video sessions or a self-directed approach to a diabetes prevention program can help people in rural areas lose weight and stay healthy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Trial ID | NCT06252038 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial aims to evaluate the effectiveness of two delivery methods of the National Diabetes Prevention Program (NDPP) in rural areas: group video sessions via Zoom and a self-directed approach. The study will assess weight loss, physical activity, and HbA1c levels among participants over a 12-month period. Additionally, it will compare different recruitment strategies to determine their impact on enrollment and retention rates. The findings will help identify best practices for delivering diabetes prevention programs in rural settings.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a BMI of 25 or higher and recent blood test results indicating prediabetes.
Not a fit: Patients with a previous diagnosis of Type I or II diabetes or those currently taking FDA-approved weight loss medications may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly reduce the incidence of diabetes among prediabetic adults in rural communities.
How similar studies have performed: Other studies have shown success with similar diabetes prevention programs, indicating a promising approach to addressing this public health issue.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * BMI ≥25 kg/m2, ≥23 kg/m2 if Asian * Blood test results in the pre diabetic range within the last year (HbA1C = 5.7%-6.4% or fasting plasma glucose= 100-125 mg/dl or 2-hr. plasma glucose following a 75-gm glucose load = 140-199 mg/dL) or have previous diagnosis of gestational diabetes or a positive screening for pre diabetes based on CDC pre diabetes risk test * Willing to travel to KSRE site for orientation and outcome testing * Available to attend pre-specified meeting time of GV for their respective KSRE location * Medically stable as deemed by primary care provider consent * English speaking Exclusion Criteria: * Previous diagnosis of Type I or II diabetes * Taking FDA-approved weight loss medications * Primary care provider stating that patient should not participate * Self-report as currently pregnant or within 6 weeks of having given birth (or planning to become pregnant in the next 12 months) * Unable to engage in physical activity
Where this trial is running
Kansas City, Kansas
- University of Kansas Medical Center — Kansas City, Kansas, United States (Recruiting)
Study contacts
- Principal investigator: Anna M Gorczyca, PhD — University of Kansas Medical Center
- Study coordinator: Annie Rice, M.S.
- Email: arice7@kumc.edu
- Phone: 785-764-3770
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.